About this trial
With the aging of the world population, osteoporosis and fragility fractures have become global public health concerns. It has been estimated the population of people ≥60 years of age will increase from 229 million (16.2%) in 2017 to 479 million (35.1%) by 2050 in China. Because age is an important predictor of osteoporosis and fragility fracture, the incidence of fragility fracture has increased dramatically in China over the past decades. Timely treatment of osteoporosis is an effective way to decrease additional fracture risk among patients with fragility fractures, but anti-osteoporosis treatment rate is relatively low in China. Effective fracture prevention intervention is urgently needed in China.
As a potential way to achieve effective risk communication, shared decision-making allows patients to be active participants in the management of osteoporosis. The investigators designed a multifaceted intervention, which was named as "Precise Education + Shared Decision-Making" program for the secondary prevention of fragility fractures based on behavioral theories, and assessed the effectiveness for fracture prevention using a pilot cluster randomized controlled trial among several hospitals in China.
The aim of this pilot study is to test the acceptability and feasibility as well as preliminary efficacy of this program in patients with fragility fractures.
Eligibility criteria
Qualifiers
Local residents (live in the city where the hospital is located for half a year or more);
Hospitalized patients with fractures aged 50 years and above;
First fracture, without history of fracture;
Never diagnosed as "osteoporosis" before admission;
Disqualifiers
Patients with pathological fractures caused by tumor or infection;
Patients with cognitive dysfunction or mental disorder;
AIDS patients;
Patients who refuse to follow-up, or have poor compliance for follow-up, or fail to understand and cooperate for follow-up;
Trial design
Treatments tested in this trial
- Multifaceted Intervention
Treatment groups
Sponsors and collaborators
Third Affiliated Hospital, Sun Yat-Sen University
Lead sponsor
Sir Run Run Shaw Hospital
Collaborator
The Second Affiliated Hospital of Hunan University of Chinese Medicine
Collaborator
Longgang Orthopedics Hospital of Shenzhen
Collaborator
The First People's Hospital of Hefei
Collaborator
Dongguan Eighth People's Hospital
Collaborator
The Third People's Hospital of Longgang District Shenzhen
Collaborator